NASDAQ · Medical - Devices

NNOX (NNOX) Stock

$1.06 +3.92% NASDAQ: NNOX Healthcare

Valuation

MetricValue
Price$1.06
Market Cap$73.78M
P/E Ratio-1.56
P/B Ratio0.90
P/S Ratio9.67
EPS (TTM)$-1.16
52-Week High$5.69
52-Week Low$0.80
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-53.57%
ROA-46.30%
ROCE-43.57%
Gross Margin-469.23%
Operating Margin-469.23%
Net Margin-5.76%
Debt/Equity0.06
Current Ratio3.94

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$9.0M$10.0M$11.0M$13.0M
Operating Profit$-62.0M$-110.0M$-63.0M$-57.0M$-61.0M
Net Profit$-62.0M$-105.0M$-61.0M$-54.0M$-75.0M
EPS$-1.28$-2.01$-1.08$-0.91$-1.16
Op Margin-4720.7%-1279.0%-631.9%-502.9%-466.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$363.0M$254.0M$219.0M$210.0M$162.0M
Total Liabilities$71.0M$37.0M$23.0M$21.0M$22.0M
Cash$67.0M$38.0M$56.0M$39.0M$49.0M
Borrowings$6.0M$5.0M$8.0M$7.0M$8.0M

Latest News

New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026 GlobeNewswire · Jul 7, 2026 Nano X Imaging Ltd (NNOX) Q1 2026 Earnings Call Highlights: Revenue Growth Amidst Financial ... GuruFocus.com · Jun 25, 2026 Nano-X Imaging Ltd. Q1 2026 Earnings Call Summary Moby · Jun 25, 2026 Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates GlobeNewswire · Jun 25, 2026 Nano X Imaging Ltd (NNOX) Q1 2026 Earnings Report Preview: What To Look For GuruFocus.com · Jun 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-38.0M$-43.0M$-45.0M$-37.0M$-41.0M
Investing Cash Flow$-139.0M$7.0M$32.0M$-23.0M$25.0M
Financing Cash Flow$4.0M$1.0M$0$2.0M$0
Net Cash Flow$-147.0M$-28.0M$18.0M$-17.0M$10.0M
Free Cash Flow$-61.0M$-51.0M$-48.0M$-39.0M$-45.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-37.81%
Quick Ratio3.77
Interest Coverage—
Return 1Y-77.90%
Return 3Y-92.81%
Return 5Y-95.84%

Ownership

Insiders Held0.35%
Institutions Held26.99%
Institutions Float Held27.08%
Institutional HolderSharesReport Date
Blackrock Inc.3,818,4442026-03-31
Weiss Asset Management Lp2,793,3392026-03-31
UBS Group AG1,348,8242026-03-31
State Street Corporation1,218,9482026-03-31
Geode Capital Management, LLC893,0982026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CATX $3.00 +1.01% -2.59 $342.14M 0.00%
HCAT $2.16 +0.93% -0.54 $159.61M 0.00%
HSDT $1.69 +0.60% -1.25 $98.67M 0.00%
INGN $6.49 +1.09% -8.00 $175.71M 0.00%
MXCT $1.18 +6.31% -2.55 $126.40M 0.00%

About NNOX

NNOX is led by CEO Erez I. Meltzer, employs 165 people, headquartered in IL, publicly traded since 2020.

NNOX stock trades at $1.06 with a market capitalization of $73.78M. The stock is valued at a price-to-earnings (P/E) ratio of -1.56, price-to-book of 0.90, price-to-sales of 9.67. Over the past 52 weeks the stock has ranged between $0.80 and $5.69, and currently trades 81.4% below its 52-week high.

On profitability, NNOX generates a return on equity (ROE) of -53.57%, return on capital employed of -43.57%, an operating margin of -469.23%, a net profit margin of -5.76%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides